353 related articles for article (PubMed ID: 35438554)
1. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
2. Anti-Respiratory Syncytial Virus Mechanism of
Du H; Ding J; Wang P; Zhang G; Wang D; Ma Q; Li N; Sun T
Comb Chem High Throughput Screen; 2021; 24(8):1137-1150. PubMed ID: 32957876
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb
Liu J; Yuan S; Yao Y; Wang J; Scalabrino G; Jiang S; Sheridan H
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891565
[TBL] [Abstract][Full Text] [Related]
5. Identifying Active Substances and the Pharmacological Mechanism of
Lai GH; Wang F; Nie DR; Lei SJ; Wu ZJ; Cao JX
Evid Based Complement Alternat Med; 2022; 2022():3776340. PubMed ID: 35360660
[TBL] [Abstract][Full Text] [Related]
6. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
8. Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology.
Ye XW; Deng YL; Zhang X; Liu MM; Liu Y; Xie YT; Wan Q; Huang M; Zhang T; Xi JH; Zhang JL
Drug Dev Ind Pharm; 2021 Aug; 47(8):1279-1289. PubMed ID: 34605344
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking.
Simayi J; Nuermaimaiti M; Wumaier A; Khan N; Yusufu M; Nuer M; Maihemuti N; Bayinsang ; Adurusul K; Zhou W
Medicine (Baltimore); 2022 Jan; 101(1):e28286. PubMed ID: 35029877
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking.
Cai Y; Zeng M; Chen YZ
Ann Palliat Med; 2021 Apr; 10(4):3864-3895. PubMed ID: 33691446
[TBL] [Abstract][Full Text] [Related]
11. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
12. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
13. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (
Wang L; Wang Y; Yang W; He X; Xu S; Liu X; He Y; Hu Q; Yuan D; Jin T
J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34313585
[No Abstract] [Full Text] [Related]
15. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
Xing Y; Hua YR; Shang J; Ge WH; Liao J
Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725
[TBL] [Abstract][Full Text] [Related]
16. Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking.
Li J; Huang Z; Lu S; Luo H; Tan Y; Ye P; Liu X; Wu Z; Wu C; Stalin A; Wang H; Liu Y; Shen L; Fan X; Zhang B; Yi J; Yao L; Xu Y; Wu J; Duan X
Medicine (Baltimore); 2021 Dec; 100(51):e27112. PubMed ID: 34941025
[TBL] [Abstract][Full Text] [Related]
17. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
Gao LQ; Xu J; Chen SD
Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the mechanism of Prunella vulgaris in treatment of papillary thyroid carcinoma based on network pharmacology integrated molecular docking and experimental verification.
Zhu X; Li Y; Wang X; Huang Y; Mao J
Medicine (Baltimore); 2023 Apr; 102(17):e33360. PubMed ID: 37115092
[TBL] [Abstract][Full Text] [Related]
19. Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking.
Hong Q; Shang X; Wu Y; Nie Z; He B
Curr Pharm Des; 2023; 29(33):2655-2667. PubMed ID: 38018195
[TBL] [Abstract][Full Text] [Related]
20. In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.
Wu H; Gong K; Qin Y; Yuan Z; Xia S; Zhang S; Yang J; Yang P; Li L; Xie M
J Ethnopharmacol; 2021 Jul; 275():114098. PubMed ID: 33831468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]